［1］ 王家良.21世纪的临床医学－循证医学［M］.北京：人民卫生出版社，2001：123 .

［2］ McNamee K, Dawood F, Farquharson R. Recurrent miscarriage and thrombophilia: an update［J］. Curr Opin Obstet Gynecol, 2012,24(4):229-234 .

［3］ Rodger MA, Betancourt MT, Clark P, et al. The association of factor V leiden and prothrombin gene mutation and placenta-mediated pregnancy complications: a systematic review and meta-analysis of prospective cohort studies［J］. PLoS Med, 2010,7(6):e1000292 . Review.

［4］ de Jong PG, Goddijn M, Middeldorp S. Testing for inherited thrombophilia in recurrent miscarriage［J］. Semin Reprod Med,2011,29(6):540-547 .

［5］ Christiansen OB, Nybo Andersen AM, Bosch E, et al. Evidence-based investigations and treatments of recurrent pregnancy loss［J］. Fertil Steril,2005,83(4):821-839 . 

［6］ Arredondo F, Noble LS. Endocrinology of recurrent pregnancy loss［J］. Semin Reprod Med,2006,24(1):33-39 .

［7］ Hanson U, Persson B, Thunell S. Relationship between haemoglobin A1C in early type 1 (insulin-dependent) diabetic pregnancy and the occurrence of spontaneous abortion and fetal malformation in Sweden［J］. Diabetologia,1990,33(2):100-104 .

［8］ Lashen H, Fear K, Sturdee DW, et al. Obesity is associated with increased risk of first trimester and recurrent miscarriage: matched case-control study［J］. Hum Reprod, 2004,19:1644-1646 .

［9］ Stephenson MD, Awartani KA, Robinson WP. Cytogenetic analysis of miscarriages from couples with recurrent miscarriage: a case-control study［J］. Hum Reprod,2002,17(2):446-451 .

［10］ Barber JC, Cockwell AE, Grant E, et al. Is karyotyping couples experiencing recurrent miscarriage worth the cost? ［J］. BJOG,2010,117(7):885-888 .

［11］ Franssen MTM, Korevaar JC, Leschot NJ, et al. Selective chromosome analysis in couples with two or more miscarriages: case-control study［J］. BMJ, 2005,331:137-139 .

［12］ Chan YY, Jayaprakasan K, Zamora J, et al. The prevalence of congenital uterine anomalies in unselected and high-risk populations: a systematic review［J］. Hum Reprod Update,2011,17(6):761-771 .

［13］ Saravelos SH, Cocksedge KA, Li TC. Prevalence and diagnosis of congenital uterine anomalies in women with reproductive failure: a critical appraisal［J］. Hum Reprod Update, 2008,14(5):415-429 .

［14］ Chan YY, Jayaprakasan K, Tan A, et al. Reproductive outcomes in women with congenital uterine anomalies: a systematic review［J］. Ultrasound Obstet Gynecol, 2011,38(4):371-382 .

［15］ Regan L, Jivraj S. Infection and pregnancy loss//MacLean AB,Regan L,Carrington D, editors. Infection and pregnancy［M］. London:RCOG Press, 2001:291-304 .

［16］ Empson M, Lassere M, Craig J,et al. Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant［J］. Cochrane Database Syst Rev, 2005,18(2):CD002859 .

［17］ Kaandorp S, Di Nisio M, Goddijn M, et al. Aspirin or anticoagulants for treating recurrent miscarriage in women without antiphospholipid syndrome［J］. Cochrane Database Syst Rev, 2009,(1):CD004734 .

［18］ Ziakas PD, Pavlou M, Voulgarelis M. Heparin treatment in antiphospholipid syndrome with recurrent pregnancy loss: a systematic review and meta-analysis［J］. Obstet Gynecol, 2010,115(6):1256-1262 .

［19］ Briggs G. Drugs in pregnancy and lactation: a reference guide to fetal and neonatal risk［M］. 5th ed. Baltimore :Williams Wilkins, 1998:73-81 .

［20］ Duley L, Henderson-Smart DJ, Meher S,et al. Antiplatelet agents for preventing pre-eclampsia and its complications［J］. Cochrane Database Syst Rev, 2007,(2):CD004659 .

［21］ Kozer E, Nikfar S, Costei A, et al. Aspirin consumption during the first trimester of pregnancy and congenital anomalies: a meta-analysis［J］. Am J Obstet Gynecol, 2002,187(6):1623-1630 .

［22］ Greer IA, Nelson-Piercy C. Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy［J］. Blood, 2005,106(2):401-407 .

［23］ Carlin AJ, Farquharson RG, Quenby SM, et al. Prospective observational study of bone mineral density during pregnancy: low molecular weight heparin versus control［J］. Hum Reprod, 2004,19(5):1211-1214 . 

［24］ Lalioti MD. Can preimplantation genetic diagnosis overcome recurrent pregnancy failure? ［J］. Curr Opin Obstet Gynecol, 2008,20(3):199-204 .

［25］ Jacobsen LJ, DeCherney A. Results of conventional and hysteroscopic surgery［J］. Hum Reprod, 1997,12(7):1376-1381 .

［26］ Drakeley AJ, Roberts D, Alfirevic Z. Cervical stitch (cerclage) for preventing pregnancy loss in women［J］. Cochrane Database Syst Rev, 2003,(1):CD003253 .

［27］ Berghella V, Mackeen AD. Cervical length screening with ultrasound-indicated cerclage compared with history-indicatedcerclage for prevention of preterm birth: a meta-analysis［J］. Obstet Gynecol, 2011,118(1):148-155 .

［28］ Haas DM, Ramsey PS. Progestogen for preventing miscarriage［J］. Cochrane Database Syst Rev, 2008,(2):CD003511 .

［29］ Scott JR, Pattison N. Human chorionic gonadotrophin for recurrent miscarriage［J］. Cochrane Database Syst Rev, 2000,(2):CD000101 .

［30］ Palomba S, Falbo A, Orio F Jr, et al. Effect of preconceptional metformin on abortion risk in polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials［J］. Fertil Steril, 2009,92(5):1646-1658 .

［31］ Jakubowicz DJ, Iuorno MJ, Jakubowicz S, et al. Effects of metformin on early pregnancy loss in the polycystic ovary syndrome［J］. J Clin Endocrinol Metab, 2002,87(2):524-529 .

［32］ Porter TF, LaCoursiere Y, Scott JR. Immunotherapy for recurrent miscarriage［J］. Cochrane Database Syst Rev, 2006,(2):CD000112 .

［33］ Stephenson MD, Kutteh WH, Purkiss S et al. Intravenous immunoglobulin and idiopathic secondary recurrent miscarriage: a multicentered randomized placebo-controlled trial［J］. Hum Reprod, 2010,25(9):2203-2209 .

［34］ Dendrinos S, Sakkas E, Makrakis E. Low-molecular-weight heparin versus intravenous immunoglobulin for recurrent abortion associated with antiphospholipid antibody syndrome［J］. Int J Gynaecol Obstet, 2009,104(3):223-225 . 

［35］ Triolo G, Ferrante A, Ciccia F, et al. Randomized study of subcutaneous low molecular weight heparin plus aspirin versus intravenous immunoglobulin in the treatment of recurrent fetal loss associated with antiphospholipid antibodies［J］. Arthritis Rheum, 2003,48(3):728-731 .